Federal Register / Vol. 73, No. 199 / Tuesday, October 14, 2008 / Notices 60719 

Dated: October 8, 2008. 

Lynn Bryant, 

Department Clearance Officer, PRA, United 

States Department of Justice. 

[FR Doc. E8–24284 Filed 10–10–08; 8:45 am] 

BILLING CODE 4410–FY–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(i), the 

Attorney General shall, prior to issuing 

a registration under this section to a 

bulk manufacturer of a controlled 

substance in schedule I or II, and prior 

to issuing a regulation under 21 U.S.C. 

952(a)(2) authorizing the importation of 

such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with Title 21 

Code of Federal Regulations (CFR), 

1301.34(a), this is notice that on August 

26, 2008, Hospira Inc., 1776 North 

Centennial Drive, McPherson, Kansas 

67460–1247, made application to the 

Drug Enforcement Administration 

(DEA) to be registered as an importer of 

Remifentanil (9739), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to import 

Remifentanil for use in dosage form 

manufacturing. 

Any bulk manufacturer who is 

presently, or is applying to be, 

registered with DEA to manufacture 

such basic classes of controlled 

substances may file comments or 

objections to the issuance of the 

proposed registration and may, at the 

same time, file a written request for a 

hearing on such application pursuant to 

21 CFR 1301.43 and in such form as 

prescribed by 21 CFR 1316.47. 

Any such comments or objections 

should be addressed, in quintuplicate, 

to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than November 13, 2008. 

This procedure is to be conducted 

simultaneously with, and independent 

of, the procedures described in 21 CFR 

1301.34(b), (c), (d), (e), and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975, 

(40 FR 43745), all applicants for 

registration to import a basic class of 

any controlled substance in schedule I 

or II are, and will continue to be, 

required to demonstrate to the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 USC 

958(a); 21 U.S.C. 823(a); and 21 CFR 

1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: October 6, 2008. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E8–24308 Filed 10–10–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a) of Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on May 13, 2008, Halo 

Pharmaceutical Inc., 30 North Jefferson 

Road, Whippany, New Jersey 07981, 

made application to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the basic classes of controlled 

substances listed in schedules I and II: 

Drug Schedule 

Dihydromorphine (9145) ............... I 

Hydromorphone (9150) ................ II 

Dihydromorphine is an intermediate 

in the manufacture of Hydromorphone 

and is not for commercial distribution. 

The company plans to manufacture 

Hydromorphone HCL for sale to other 

manufacturers and for the manufacture 

of other controlled substance dosage 

units for distribution to its customers. 

Any other such applicant, and any 

person who is presently registered with 

DEA to manufacture such substances, 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than December 15, 2008. 

Dated: October 7, 2008. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E8–24310 Filed 10–10–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket Nos. 05–13 and 05–45] 

Sunny Wholesale, Inc. Revocation of 

Registration and Denial of Application; 

Correction 

On October 3, 2008, the Drug 

Enforcement Administration (DEA) 

published an order in the Federal 

Register (73 FR 57655) that, among 

other things, revoked the registration of 

Sunny Wholesale, Inc. In the order 

taking this action, the DEA Certificate of 

Registration was incorrectly cited. The 

correct Certificate of Registration for 

Sunny Wholesale, Inc., 120 Forest 

Parkway, Forest Park, Georgia, is 

004550SLY. 

Therefore, the Certificate of 

Registration referenced at 73 FR 57668, 

first column, sixth line down, is 

corrected to read ‘‘004550SLY.’’ 

Dated: October 6, 2008. 

Michele M. Leonhart, 

Deputy Administrator. 

[FR Doc. E8–24305 Filed 10–10–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Office of Justice Programs 

[OMB Number 1121–NEW] 

Agency Information Collection 

Activities: New Information Collection, 

Comments Requested 

ACTION: 30-Day Notice of Information 

Collection Under Review: NICS Act 

State Record Estimates Data Collection. 

The Department of Justice (DOJ), 

Office of Justice Programs, Bureau of 

Justice Statistics (BJS), will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

The proposed information collection is 

published to obtain comments from the 

public and affected agencies. This 

proposed information collection was 

previously published in the Federal 

Register Volume 73, Number 150, page 

45245 on August 4, 2008, allowing for 

a 60 day comment period. 

The purpose of this notice is to allow 

for an additional 30 days for public 

comment until November 13, 2008. This 

process is conducted in accordance with 

5 CFR 1320.10. 

The proposed information collection 

is available online at http:// 

www.ojp.usdoj.gov/bjs/niaa.htm. 


jlentini on PROD1PC65 with NOTICES